The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Imaging peritoneal metastasis of gastric cancer with PET/CT and the radiotracer 18F-fluorothymidine (18F-FLT):Proof-of-concept study.
 
Yoshitaka Honma
No Relationships to Disclose
 
Takashi Terauchi
No Relationships to Disclose
 
Ukihide Tateishi
No Relationships to Disclose
 
Daisuke Kano
No Relationships to Disclose
 
Kengo Nagashima
No Relationships to Disclose
 
Natsuko T. Okita
Research Funding - Novartis (Inst); Teijin Pharma (Inst)
 
Atsuo Takashima
Honoraria - Chugai Pharma
 
Satoru Iwasa
Honoraria - Chugai Pharma; Takeda
 
Ken Kato
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Dainippon Sumitomo Pharma; Lilly; Nippon Kayaku; Pfizer; Sanofi; Taiho Pharmaceutical
Research Funding - Daiichi Sankyo (Inst); Merck Serono (Inst); Ono Pharmaceutical (Inst)
 
Tetsuya Hamaguchi
Honoraria - Chugai Pharma; Kyowa Hakko Kirin; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Consulting or Advisory Role - Takeda
Research Funding - Dainippon Sumitomo Pharma (Inst); NanoCarrier (Inst)
 
Yasuhiro Shimada
Honoraria - Bayer; Chugai Pharma; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Chugai Pharma (Inst); Lilly (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
 
Narikazu Boku
Honoraria - Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Shionogi
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Yasuhide Yamada
Honoraria - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Dainippon Sumitomo Pharma; Novartis; Pfizer; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Merck Serono; Novartis; Otsuka; Taiho Pharmaceutical